CGT

868개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved868 programs
CGTLimited DatastaleSeigo NishidaPhase 1

Liver NK cell inoculation (Liver NK cell inoculation)

Liver Cirrhosis; Hepatocellular Carcinoma · Liver Cirrhosis

#LiverCirrhosis#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleOriCell Therapeutics Co., Ltd.Phase 2

OriCAR-017 (OriCAR-017)

Relapsed and/or Refractory Multiple Myeloma · Neoplasms, Plasma Cell

#NeoplasmsPlasmaCell#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

SC-CAR.GPC3xIL15.21 CAR T cells (SC-CAR.GPC3xIL15.21 CAR T cells)

Solid Tumor (Excluding CNS); Hepatocellular Carcinoma · Solid Tumor (Excluding CNS)

#SolidTumorExcludingCNS#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleSeoul National University Hospi…Phase 2

SNUH-CD19-CAR-T (SNUH-CD19-CAR-T)

Very High Risk Acute Lymphoblastic Leukemia; CD19 CAR-T Therapy · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleGuangdong ProCapZoom Bioscience…Phase 1

SZ011 CAR-NK (SZ011 CAR-NK)

Ovarian Epithelial Carcinoma · Advanced Triple Negative Breast Cancer

#AdvancedTripleNegativeBreastCanc#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleProstate Cancer FoundationPhase 1

TmPSMA-02 CAR T Cells (TmPSMA-02 CAR T Cells)

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) · PSMA

#PSMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleShanghai Xiniao Biotech Co., Lt…Phase 1

UCAR T-cell group (UCAR T-cell group)

Systemic Lupus Erythematosus · Myasthenia Gravis

#MyastheniaGravis#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleAvenCell Europe GmbHPhase 1

IMP (UniCAR02-T, UniCAR02-T (IMP))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Discontinued
CGTLimited DatastaleThe First Affiliated Hospital w…Phase 1

allogeneic CAR-T (allogeneic CAR-T)

Graves Disease · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleKite, A Gilead CompanyPhase 1

anti-CD19 CAR-T (anti-CD19 CAR-T)

B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

anti-CD19 IL10/IL15 CAR-NK (anti-CD19 IL10/IL15 CAR-NK)

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleCity of Hope Medical CenterPhase 1

autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells)

Adult Grade III Lymphomatoid Granulomatosis; Cutaneous B-cell Non-Hodgkin Lymphoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleIIT MediTech (Jiangsu) Co. LtdPhase 2

fhB7H3.CAR-Ts (fhB7H3.CAR-Ts)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

αPD1-MSLN-CAR T cells (αPD1-MSLN-CAR T cells)

Colorectal Cancer; Ovarian Cancer · Non-small-cell Lung Cancer

#Non-small-cellLungCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleCancer Research UKPhase 1

1RG-CART (1RG-CART)

Relapsed or Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR19 and 4SCAR123 (4SCAR19 and 4SCAR123)

B-cell Malignancies · B-cell Malignancies

#B-cellMalignancies#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR19 and 4SCAR20 (4SCAR19 and 4SCAR20)

B-cell Malignancies · B-cell Malignancies

#B-cellMalignancies#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR19 and 4SCAR22 (4SCAR19 and 4SCAR22)

B-cell Malignancies · B-cell Malignancies

#B-cellMalignancies#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR19 and 4SCAR30 (4SCAR19 and 4SCAR30)

B-cell Malignancies · B-cell Malignancies

#B-cellMalignancies#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR19 and 4SCAR38 (4SCAR19 and 4SCAR38)

B-cell Malignancies · B-cell Malignancies

#B-cellMalignancies#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting

13 / 44 pages

← PreviousNext →